Mutant SOD1 expressed by oligodendrocytes aggregates in myelinic nanochannels and accelerates disease progression in familial ALS mice
Mot, A. I.; Li, Y.; Dibaj, P.; Tzvetanova, I. D.; Gerwig, U. C.; Bogale, T. A.; Goebbels, S.; Möbius, W.; Bergles, D. E.; Morrison, B. M.; Rothstein, J. D.; Cleveland, D. W.; Edgar, J. M.; Nave, K.-A.
Show abstract
Amyotrophic lateral sclerosis (ALS) is a highly debilitating and fatal disease characterized by the progressive loss of motor neurons. Reduced oligodendroglial support has been implicated in ALS progression but remains mechanistically unexplained. Here, using a mutant superoxide dismutase 1 (SOD1-G37R) mouse model of familial ALS, Cre-mediated excision of the mutant SOD1 gene within the oligodendrocyte lineage prior to myelin compaction is shown to slow disease onset, improve motor performance, and prolong survival. In contrast, silencing mutant SOD1 expression within oligodendrocytes after myelin compaction failed to ameliorate disease phenotype. Electron microscopy is used to identify aggregation of mutant SOD1 within paranodal loops and the inner periaxonal tongue of myelinic nanochannels, narrow cytosolic compartments for the diffusion of metabolites and motor-driven transport processes. In a second mouse model (SOD1-G93A) of familial, SOD1 mutant-mediated ALS, we show that induction of excessive myelin compaction and myelinic channel collapse (by depletion of CNP from myelin) accelerates disease and diminishes survival. Our data support loss of myelinic channel integrity as a contributor to familial ALS disease initiation and progression, findings likely relevant to neurodegenerative disease involving other aggregation prone proteins that are expressed in myelinating oligodendrocytes. Significance StatementOligodendrocytes have been implicated in the progression of amyotrophic lateral sclerosis (ALS) but the underlying mechanisms have remained obscure. Here we show in genetic mouse models that the familial ALS causing isoform of a ubiquitously expressed mutant enzyme (SOD1) aggregates in cytosolic channels within myelin that are responsible for delivery of transporters and nutrients necessary to support the axonal compartment. ALS disease progression was accelerated in mice when myelinic channels were collapsed by deleting CNP, a structural protein necessary for myelinic channel maintenance. Disruption of transport through myelinic channels by aggregation of mutant SOD1 may perturb oligodendrocyte support of motor axons and contribute to disease in this form of ALS.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A panel of TDP-43-regulated splicing events verify loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue 96%
- Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy 94%
- Reduction in CD11c+ microglia correlates with clinical progression in chronic experimental autoimmune demyelination 93%
Similar papers in this journal
- Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS 95%
- Neuronal TDP-43 aggregation drives changes in microglial morphology prior to immunophenotype in amyotrophic lateral sclerosis 94%
- α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response 93%
Similar papers in this journal
- Microglial ferroptotic stress causes non-cell autonomous neuronal death 95%
- VPS35 and α-Synuclein Fail to Interact to Modulate Neurodegeneration in Rodent Models of Parkinson's Disease 95%
- Network Analysis of the Cerebrospinal Fluid Proteome Reveals Shared and Unique Differences Between Sporadic and Familial Forms of Amyotrophic Lateral Sclerosis 93%
Similar papers in this journal
- The proteasome regulator PI31 is required for protein homeostasis, synapse maintenance and neuronal survival in mice 94%
- Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinsons disease 94%
- miR-146a is a Pleiotropic Regulator of Motor Neuron Degeneration 94%
Similar papers in this journal
- MCOLN1 gene-replacement therapy corrects neurologic dysfunction in the mouse model of mucolipidosis IV. 94%
- Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice 94%
- Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic transcript dysregulation in vitro 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.